Sensorion Announces Participation in the 47th Annual Meeting of the Association for Otorhinolaryngology Research ARO
Montpellier, January 29, 2024, at 7:30 a.m. CET – Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company specializing in the development of new therapies to restore, treat and prevent hearing loss disorders, announces its participation in the 47th Annual Meeting of the Association for Research in Otolaryngology (ARO), to be held February 3-7, 2024, in Anaheim, California, United States of America.
Laurent Désiré, Ph.D., Head of Preclinical Development at Sensorion, will provide the following presentations at the ARO meeting: